Assessment of pancreatic fat content in subjects with lower and higher pancreatic fat content undergoing 3T magnetic resonance imaging (multi-echo GRE Dixon sequence) from the general population.

<p>Pancreatic fat content was measured as proton-density fat fraction (PDFF_panc) in a region of interest (red circle). L = liver; S = spleen.</p

Scatter plots for correlations of pancreatic fat content with VAT, SAT, PDFF_hepatic and BMI.

<p>Scatter plots for correlations of pancreatic fat content with VAT, SAT, PDFF_hepatic and BMI.</p

Differences of pancreatic fat content between controls, subjects with prediabetes and diabetes displayed by box-and-whisker.

<p>Differences of pancreatic fat content between controls, subjects with prediabetes and diabetes displayed by box-and-whisker.</p

Multivariate associations between demographics, cardiometabolic risk factors and pancreatic fat content.

<p>Multivariate associations between demographics, cardiometabolic risk factors and pancreatic fat content.</p

Histopathological findings.

<p>Histopathological findings.</p

Standard microspheres–standard CT findings.

<p>SMS.a. Non-enhanced CT 2 hours after embolization. In contrast to the other study groups, there was neither arterial nor parenchymal enhancement.</p

Univariate analysis of associations between demographic and cardiometabolic risk factors and pancreatic fat content.

<p>β-coefficients derived from median regression, CI, confidence interval. PDFF: proton-density fat fraction.</p

Radiopaque microspheres–standard CT findings.

<p><b>A</b> RMS.a. Non-enhanced CT 2 hours after embolization. Marked linear hyperdensity (blue asterisk) corresponding to an occluded subsegmental artery (arterial enhancement). The type of arterial enhancement was comparable to iodized oil. <b>B</b> RMS.sa. Non-enhanced CT 2 hours after embolization. Linear (blue asterisk) and patchy hyperdensities (red asterisk) corresponding to occluded subsegmental and interlobular arteries and sinusoids (arterial and parenchymal enhancement). Note the more intense arterial and parenchymal enhancement compared to A. The type of arterial and parenchymal enhancement was comparable with iodized oil. <b>C</b> RMS-HEP.sa. Non-enhanced CT 2 hours after embolization. Note the more intense arterial (blue asterisk) and parenchymal enhancement (red asterisk) than A and B. <b>D</b> RMS-HEP.sa. Non-enhanced CT 7 days after embolization. Note the weaker arterial (blue asterisk) and parenchymal (red asterisk) enhancement compared to C. Note the hypodense areas in the embolized liver parenchyma (blue arrowhead) representing tissue necrosis.</p

Iodized oil–standard CT findings.

<p><b>A</b> IO.a. Non-enhanced CT 2 hours after embolization with 0.5 mL iodized oil. Linear hyperdensities (blue asterisk) corresponding to an occluded subsegmental artery (arterial enhancement) and patchy hyperdensities (red asterisk) corresponding to occluded interlobular arteries and sinusoids (parenchymal enhancement). <b>B</b> IO.sa. Non-enhanced CT 2 hours after embolization. Note the lower arterial (blue asterisk) and parenchymal (red asterisk) enhancement compared to A. <b>C</b> IO.sa. Non-enhanced CT 7 days after embolization. Note the less intense arterial (blue asterisk) and parenchymal (red asterisk) enhancement compared to B.</p

Standard CT findings.

<p>Standard CT findings.</p